| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f53bbb3a1633b300be9724cb7a72934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e59372b330374bf4bfee2c1cfd3dc54b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_625560b34ee24071db3a85f57ef0ddf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9cd8917e11b7f80ff4607e1203bb9fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-33396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 |
| filingDate |
2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4e1fce6ebb0240c9e912a90a908f723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_759a930621682a0947ed84cda2b05020
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df61ea2be202ae5a203f8ee4275e058 |
| publicationDate |
2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8178494-B2 |
| titleOfInvention |
Modified human growth hormone formulations with an increased serum half-life |
| abstract |
Formulations of modified growth hormone polypeptides are provided, including human growth hormone polypeptides with one or more non-naturally encoded amino acids with an increased half-life. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962450-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014296145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11129906-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10253083-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751391-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9567386-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10266578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364281-B2 |
| priorityDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |